This inventor holds 1 USPTO granted patent. Top assignee: Cambridge Antibody Technology Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Detlef Güssow: Innovator in Single Domain Ligands
Introduction
Detlef Güssow is a prominent inventor based in Cambridge, GB. He is known for his significant contributions to the field of biotechnology, particularly in the development of single domain ligands. His work has implications for therapeutic and diagnostic applications, showcasing the intersection of science and innovation.
Latest Patents
Detlef Güssow holds a patent for "Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors." This invention relates to single domain ligands derived from molecules in the immunoglobulin (Ig) superfamily. The patent outlines methods for cloning, amplifying, and expressing DNA sequences encoding such ligands, preferably using the polymerase chain reaction. It also discusses the use of these ligands and receptors in therapy, diagnosis, or catalysis. He has 1 patent to his name.
Career Highlights
Güssow has made significant strides in his career, particularly through his work at Cambridge Antibody Technology Limited. His innovative approaches have contributed to advancements in the field of immunology and biotechnology. His research has paved the way for new therapeutic strategies and diagnostic tools.
Collaborations
Detlef Güssow has collaborated with notable scientists in his field, including Gregory Paul Winter and Elizabeth Sally Ward. These collaborations have further enhanced the impact of his work and have led to significant advancements in the understanding and application of single domain ligands.
Conclusion
Detlef Güssow's contributions to the field of biotechnology, particularly through his patent on single domain ligands, highlight his role as an innovator. His work continues to influence therapeutic and diagnostic applications, making a lasting impact in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
